In this article, we will look at the 9 Best Affordable Stocks Under $5 to Buy for the Next 3 Years.

On December 5, Jeremy Siegel, Wharton professor emeritus and WisdomTree chief economist, appeared on CNBC’s ‘Closing Bell’ to talk about his thoughts on equity markets.

He stated that the market looks “very, very solid” to him, but we can not rely on seasonal predictions to gauge the market, as everyone was of the opinion that September and October are usually weak months, while November is usually considered the best month of the year, which “squeaked out” just a little bit of a gain.

December, according to Siegel, is usually a good month as well, but can go either way; one of the most reliable periods for December is the trading days between Christmas and New Year’s, which are up almost 90% of the time. So, the market could reach new levels.

READ ALSO: 10 Best Low Volatility Large Cap Stocks to Invest In and 13 Best Large Cap Stocks to Invest in For the Long Term.

Siegel further stated that he is pleased in terms of holidays, with Black Friday and Cyber Monday both performing well despite his fears that tariffs may impact sales. Although the two days were not gangbusters, they still show an economy that is moving at a probably 2% or 2.5% GDP pace.

With these trends in view, let’s look at the best affordable stocks under $5 to buy for the next 3 years.

Our Methodology 

We used Finviz and Seeking Alpha to compile a list of stocks under $5 with a forward P/E below 15 and a positive long term forward EPS growth rate (3-5Y CAGR). We then selected the top 9 stocks with the highest number of hedge fund holders as of Q3 2025, sourcing the hedge fund sentiment data from Insider Monkey’s database. The list is sorted in ascending order of hedge fund sentiment.

Note: All data was recorded on December 4.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 427.7% since May 2014, beating its benchmark by 264 percentage points (see more details here).

9 Best Affordable Stocks Under $5 to Buy for the Next 3 Years

9. CI&T Inc (NYSE:CINT)

Forward P/E: 14.01

Stock Price: $4.86

​Long Term Forward EPS Growth Estimate (3-5Y CAGR): 29.20%

Number of Hedge Fund Holders: 8

CI&T Inc (NYSE:CINT) is one of the best affordable stocks under $5 to buy for the next 3 years. CI&T Inc (NYSE:CINT) announced on December 5 that CFO Niels Boon would be transitioning out of the role after bolstering the company’s financial foundation. To ensure a smooth transition, he would remain with the company for the upcoming six months. Management stated that no change would occur in the company’s priorities, operations, and day-to-day business.

Separately, JPMorgan lowered the price target on CI&T Inc (NYSE:CINT) to $7 from $8 on November 13 while keeping an Overweight rating on the shares. The rating update came after the company reported its fiscal Q3 2025 results on October 24, with the firm telling investors that CI&T Inc’s (NYSE:CINT) sales growth is outpacing its peers.

Similarly, Canaccord also slashed the price target on the stock to $6 from $8 on November 13, but maintained a Buy rating on the shares, telling investors that while CI&T Inc (NYSE:CINT) delivered strong performance in Latin America, growth appears to be broadening. This is taking place in a backdrop where the weight of its largest client, accounting for 40% of its revenue, is tapering. The firm clarified that this is not taking place because the client is slowing, but rather because the rest of the company’s base is accelerating.

Wedbush analyst Daniel Ives, however, maintained his bullish stance on CI&T Inc (NYSE:CINT) the same day, reiterating a Buy rating with a $9.00 price target.

CI&T Inc’s (NYSE:CINT) net sales in fiscal Q3 2025 amounted to EUR 33.7 million, corresponding to a 20.4% drop, or 16.2% on a constant currency basis. Management stated that the weakening of the USD had a negative effect on reported growth, and revenues were affected by a challenging business climate as well as the migration of the company’s largest customers.

CI&T Inc (NYSE:CINT) offers design, strategy, and software engineering services to allow digital transformation. The company’s services and solutions include Digital Strategy, Customer-Centric Design, and Top-of-the-Line Software Engineering.

8. TTEC Holdings, Inc. (NASDAQ:TTEC)

Forward P/E: 3.39

Stock Price: $3.70

​Long Term Forward EPS Growth Estimate (3-5Y CAGR): 12.00%

Number of Hedge Fund Holders: 16

TTEC Holdings, Inc. (NASDAQ:TTEC) is one of the best affordable stocks under $5 to buy for the next 3 years. TTEC Holdings, Inc. (NASDAQ:TTEC) announced on November 25 a major expansion of its Egypt operations after the 2025 Global Offshoring Summit in Cairo.

TTEC Engage President John Abou met with senior Egyptian government leaders during the visit, including the Prime Minister of Egypt and Minister of ICT, participated in a Presidential Roundtable, and signed a Memorandum of Understanding (MOU) with the Information Technology Industry Development Agency supporting the scaling of the company’s Cairo operations. The agreement entails the expansion of TTEC Holdings, Inc.’s (NASDAQ:TTEC) workforce by an additional 3,500 employees by 2029 to meet growing global client demand.

Separately, on November 10, Craig-Hallum analyst George Sutton maintained a Buy rating on TTEC Holdings, Inc. (NASDAQ:TTEC) and set a $5.00 price target.

However, the same day, the stock was downgraded to Market Perform from Outperform by William Blair analyst Maggie Nolan without a price target. The firm told investors that it sees “modest risk” in the company’s reiterated 2025 guidance, especially for profitability. It believes that TTEC Holdings, Inc.’s (NASDAQ:TTEC) free cash flow generation is challenged while its debt remains high, and that it expects the company’s transition to lead to slow margin recovery and pressured growth.

TTEC Holdings, Inc. (NASDAQ:TTEC) is a digital global customer experience technology and services company that focuses on the implementation, design, and delivery of transformative solutions for several brands. The company’s operations are divided into the TTEC Digital and TTEC Engage segments.

7. ACCO Brands Corporation (NYSE:ACCO)

Forward P/E: 4.3

Stock Price: $3.57

​Long Term Forward EPS Growth Estimate (3-5Y CAGR): 10.00%

Number of Hedge Fund Holders: 16

ACCO Brands Corporation (NYSE:ACCO) is one of the best affordable stocks under $5 to buy for the next 3 years. Barrington analyst Kevin Steinke maintained a Buy rating on ACCO Brands Corporation (NYSE:ACCO) on November 6, setting a $6.00 price target. Noble Financial analyst Joe Gomes also expressed bullish sentiments for the stock on November 3, reiterating a Buy rating with a $9.00 price target.

The rating updates followed ACCO Brands Corporation’s (NYSE:ACCO) release of fiscal Q3 2025 results on October 30, with reported net sales of $384 million. Gross margin expanded by 50 basis points as the company continued to exhibit strong operational discipline through the continual execution of its $100 million cost reduction program. The company’s multi-year cost reduction program has yielded over $50 million of savings.

Management further reported that sales in the quarter were lower than expected, primarily because the demand environment for several of the company’s categories remained soft globally. ACCO Brands Corporation (NYSE:ACCO) expects an improvement in sales trends in Q4, reflecting the growth in the technology accessories categories along with the favorable impact of foreign exchange.

ACCO Brands Corporation (NYSE:ACCO) is involved in the manufacture and marketing of school, office, and calendar products, along with select computer and electronic accessories. The company operates through the following segments: ACCO Brands North America, ACCO Brands EMEA, and ACCO Brands International.

6. Ultrapar Participações S.A. (NYSE:UGP)

Forward P/E: 10.31

Stock Price: $4.34

​Long Term Forward EPS Growth Estimate (3-5Y CAGR): 5.16%

Number of Hedge Fund Holders: 17

Ultrapar Participações S.A. (NYSE:UGP) is one of the best affordable stocks under $5 to buy for the next 3 years. On November 13, Scotiabank maintained a Buy rating on Ultrapar Participações S.A. (NYSE:UGP), setting a price target of BRL26.00. The same day, the stock was upgraded to Outperform from Neutral by Bradesco BBI with a R$30 price target.

The rating updates came after Ultrapar Participações S.A. (NYSE:UGP) reported its fiscal Q3 2025 results on November 12, with revenue for the quarter reaching R$37.1 billion and net income of R$0.8 billion. Cash generated from operations for the quarter amounted to R$2.1 billion, while adjusted EBITDA reached R$1.9 billion.

The company also provided updates regarding the advances made in its growth and strategic positioning agenda, including the completion of the expansion of the Santos terminal, which added  34,000 m³ of storage capacity at Ultracargo in October 2025. Ultrapar Participações S.A. (NYSE:UGP) also closed the sale of coastal navigation operation (cabotage) by Hidrovias on November 1 for R$715 million, bolstering its financial position while allowing focus on more synergistic and complementary businesses.

Ultrapar Participações S.A. (NYSE:UGP) is involved in distribution and retail services such as fuel, retail pharmacy, LPG, specialty chemicals, and liquid bulk storage businesses. The company’s operations are divided into the following segments: Ultragaz, Ipiranga, Oxiteno, Ultracargo, Extrafarma, and Others.

5. Ambev S.A. (NYSE:ABEV)

Forward P/E: 14.46

Stock Price: $2.60

​Long Term Forward EPS Growth Estimate (3-5Y CAGR): 5.26%

Number of Hedge Fund Holders: 20

Ambev S.A. (NYSE:ABEV) is one of the best affordable stocks under $5 to buy for the next 3 years. Ambev S.A. (NYSE:ABEV) was downgraded to Market Perform from Outperform by Bernstein on November 26, who assigned a $2.88 price target to the stock.

The firm supported the rating downgrade with the company’s valuation, stating that the shares rose 16% year-to-date. While Bernstein continues to like the company’s long-term fundamentals, it told investors that it believes the current expectations to now  be “overblown”, and thus recommends that investors take profits and wait for a more attractive entry point.

Ambev S.A. (NYSE:ABEV) also received a rating update from Goldman Sachs analyst Thiago Bortoluci on November 11, who maintained a Sell rating on the stock and set a $1.95 price target.

The rating updates came after Ambev S.A. (NYSE:ABEV) released its fiscal Q3 results on October 30, with net revenue (organic) for the quarter rising 1.2% compared to last year. Management stated that top-line performance was driven by a 7.4% net revenue per hectoliter growth.

Gross margin also expanded by 10 bps to 51.5% and normalized EBITDA margin expanded by 50 bps to 33.9%, supported by cost management and effective revenue. However, high cash taxes led to cash flow from operating activities dropping by 14.7% compared to R$8.108 billion in fiscal Q3 2024.

The company also reported that normalized EBITDA also rose by 2.9%, with all its business units delivering growing or flat EBITDA. Normalized EBITDA margin expanded by 50 bps to 33.9%, attributed to effective revenue and costs management by the company.

Ambev S.A. (NYSE:ABEV) produces, distributes, and sells beverages. Its offerings include carbonated soft drinks, beer, and other non-alcoholic and non-carbonated products. The company’s operations are divided into the following geographical segments: Brazil, Central America and the Caribbean (CAC), and Canada.

4. GoodRx Holdings, Inc. (NASDAQ:GDRX)

Forward P/E: 6.57

Stock Price: $2.73

​Long Term Forward EPS Growth Estimate (3-5Y CAGR): 12.96%

Number of Hedge Fund Holders: 21

GoodRx Holdings, Inc. (NASDAQ:GDRX) is one of the best affordable stocks under $5 to buy for the next 3 years. BofA slashed the price target on GoodRx Holdings, Inc. (NASDAQ:GDRX) to $3 from $3.40 on November 17 while maintaining an Underperform rating on the shares. The firm released the rating update after the company announced two significant initiatives regarding its weight loss offerings.

GoodRx Holdings, Inc. (NASDAQ:GDRX) announced on November 17 the launch of two initiatives to boost the availability of FDA-approved GLP-1 medications, with the first initiative marking the launch of GoodRx for Weight Loss, a telemedicine subscription. The subscription would serve as a bridge between consumers and licensed healthcare providers for the provision for affordable weight management treatments.

The second initiative was released in partnership with Novo Nordisk, and entails a new introductory cash price of $199 per month for Ozempic and Wegovy injection pens, available to GoodRx users.

BofA thus told investors that it sees the announcement positively, since the collaboration not only expands the subscription offering but also builds on the company’s existing partnership with Novo Nordisk. While the firm acknowledged GoodRx Holdings, Inc.’s (NASDAQ:GDRX) progress in the expansion of its partnerships, it maintained an Underperform rating on the stock due to the reimbursement changes in the pharmacy ecosystem and the broader headwinds from pharmacy closures.

Separately, JPMorgan and TD Cowen slashed their price targets on GoodRx Holdings, Inc. (NASDAQ:GDRX) on November 11 and November 10, respectively. JPMorgan analyst Lisa Gill brought the price target down to $5 from $6 while keeping an Overweight rating on the shares, while TD Cowen lowered the price target to $6 from $7 while maintaining a Buy rating.

TD Cowen told investors that while some of the company’s new offerings are promising and its role in Cigna’s new PBM model is also potentially positive, material impact remains unlikely until at least 2027, and thus valuation overly discounts the weaker near-term outlook.

GoodRx Holdings, Inc. (NASDAQ:GDRX) offers a consumer-focused digital healthcare platform that provides free consumer access to convenient medical provider consultations through telehealth, reduced prices for brand and generic medications, and extensive healthcare research and information.

3. Playtika Holding Corp. (NASDAQ:PLTK)

Forward P/E: 6.41

Stock Price: $4.17

​Long Term Forward EPS Growth Estimate (3-5Y CAGR): 5.61%

Number of Hedge Fund Holders: 27

Playtika Holding Corp. (NASDAQ:PLTK) is one of the best affordable stocks under $5 to buy for the next 3 years. Citi slashed the price target on Playtika Holding Corp. (NASDAQ:PLTK) to $7 from $8 on November 17 and kept a Buy rating on the shares.

TD Cowen analyst Doug Creutz also maintained a Buy rating on the stock on November 6, setting a $14 price target. However, the same day, Roth MKM analyst Eric Handler reiterated a Hold rating on Playtika Holding Corp. (NASDAQ:PLTK) and set a price target of $4.

The rating updates followed the company’s release of fiscal Q3 2025 results on November 6, with revenues for the quarter reaching $674.6 million, reflecting a 3.1% decrease sequentially and an 8.7% year over year growth. Playtika Holding Corp. (NASDAQ:PLTK) also reported record DTC platforms revenue of $209.3 million, corresponding to a 19.0% growth sequentially and 20.0% year over year growth.

Management stated that record DTC revenue was supported by broad-based contributions from Bingo Blitz, June’s Journey, Solitaire Grand Harvest, and the company’s SuperPlay portfolio. Playtika Holding Corp.’s (NASDAQ:PLTK) strategy to grow its DTC mix, deepen player relationships, and reallocate resources toward the highest return opportunities is bolstering its portfolio and allowing it to support long-term cash generation.

Playtika Holding Corp. (NASDAQ:PLTK) is a developer of mobile games that owns and manages around 15 games. Its Playtika Boost Platform offers a proprietary technology that supports a portfolio of games and live game operations services. The company’s offerings include casual games, casino-themed games, and free-to-play mobile games. Its game portfolio includes Slotomania, Bingo Blitz, House of Fun, Caesars Slots, World Series of Poker, Best Fiends, June’s Journey, Solitaire Grand Harvest, and Board Kings. These games are available on the Google Play Store and iOS App Store.

2. Coty Inc. (NYSE:COTY)

Forward P/E: 8.18

Stock Price: $3.38

​Long Term Forward EPS Growth Estimate (3-5Y CAGR): 33.07%

Number of Hedge Fund Holders: 30

Coty Inc. (NYSE:COTY) is one of the best affordable stocks under $5 to buy for the next 3 years. On November 28, Morgan Stanley analyst Dara Mohsenian reiterated a Hold rating on Coty Inc. (NYSE:COTY), setting a price target of $4.25.

Coty Inc. (NYSE:COTY) was also initiated with a Neutral rating by Rothschild & Co Redburn on November 25, who assigned the stock a $3.60 price target and stated that while it sees some upside to the company’s shares, it thinks that Coty Inc.’s (NYSE:COTY) risk/reward balance “is not compelling enough.” The firm added that the company is experiencing limited clarity on its strategic review, along with increased uncertainty on its category growth.

The rating updates followed Coty Inc.’s (NYSE:COTY) fiscal Q1 2026 results on November 5, with net revenue dropping 6% on a reported basis to $1.577 billion, including a 2% benefit from FX, and dropping 8% on an LFL basis.

In addition, adjusted EPS of $0.12 dropped from adjusted EPS of $0.15 in the prior year period, and included a negative impact of $0.03 from the equity swap mark-to-market. Management, however, stated that the results for the quarter were largely in line with expectations and expressed confidence in Coty Inc. (NYSE:COTY) returning to profitable sales growth in H2 2026 and beyond, supported by the company’s strengthening execution, especially in the US market, along with market-leading fragrance innovations and strategic initiatives.

Coty, Inc. (NYSE:COTY) is a beauty company that operates a portfolio of brands in color cosmetics, fragrance, and skin and body care. Its Prestige segment operates an array of luxury brands, including Gucci, Marc Jacobs, Miu Miu, Tiffany & Co., Kylie Cosmetics by Kylie Jenner, Hugo Boss, Burberry, Chloe, Calvin Klein, SKKN BY KIM, and more. Coty, Inc.’s (NYSE:COTY) mass beauty products are primarily sold through supermarkets, hypermarkets, drugstores, department stores, e-commerce retailers, and other channels.

1. B2Gold Corp. (NYSE:BTG)

Forward P/E: 8.61

Stock Price: $4.58

​Long Term Forward EPS Growth Estimate (3-5Y CAGR): 67.36%

Number of Hedge Fund Holders: 37

B2Gold Corp. (NYSE:BTG) is one of the best affordable stocks under $5 to buy for the next 3 years. On November 21, CIBC slashed the price target on B2Gold Corp. (NYSE:BTG) to $6 from $6.50 while maintaining a Neutral rating on the shares. The firm told investors that it updated the company’s model to take into account the fiscal Q3 report and cited the higher costs at the company’s Goose Mine, along with reduced production, as headwinds to the stock in the quarter.

Similarly, Stifel also lowered the price target on B2Gold Corp. (NYSE:BTG) to C$10.50 from C$11.50 on November 11 while maintaining a Buy rating.

The rating updates followed B2Gold Corp.’s (NYSE:BTG) fiscal Q3 2025 results released on November 5, reporting total gold production of 254,369 ounces, including pre-commercial production from the Goose Mine. Management reported that the Fekola, Masbate, and Otjikoto mines all surpassed the expected production in the quarter, and the company believes that it is on track for fiscal Q4 2025 to be the strongest gold production quarter in 2025.

B2Gold Corp. (NYSE:BTG) is keeping the consolidated production guidance unchanged for the Fekola Complex, Masbate, and Otjikoto mines, anticipated to be between 890,000 and 965,000 ounces of gold. However, the company modified the 2025 gold production guidance for the Goose Mine to between 50,000 to 80,000 ounces from the previous guidance range of 80,000 to 110,000 ounces. This is primarily due to crushing plant issues and lower than budgeted gold grades brought about by temporary delays in the access of higher-grade ore from Umwelt underground in Q3 and early Q4 2025.

B2Gold Corp. (NYSE:BTG) is an exploration company that acquires and develops mineral properties. Its operations are divided into the following segments: Fekola Mine, Fekola Regional, Masbate Mine, Otjikoto Mine, Goose Project, Other Mineral Properties, and Corporate and Other.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.